Neuropsychopharmacology - Table of Contents alert Volume 40 Issue 5

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 40, Issue 5 (April 2015) In this issue Original Articles Corrigenda Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Original Articles Top The Corticotropin Releasing Hormone-1 (CRH1) Receptor Antagonist Pexacerfont in Alcohol Dependence: A Randomized Controlled Experimental Medicine Study Laura E Kwako, Primavera A Spagnolo, Melanie L Schwandt, Annika Thorsell, David T George, Reza Momenan, Daniel E Rio, Marilyn Huestis, Sebastien Anizan, Marta Concheiro, Rajita Sinha and Markus Heilig Neuropsychopharmacology 2015 40: 1053-1063; advance online publication, November 20, 2014; 10.1038/npp.2014.306 Abstract | Full Text The CRH1 Antagonist GSK561679 Increases Human Fear But Not Anxiety as Assessed by Startle Christian Grillon, Elizabeth Hale, Lynne Lieberman, Andrew Davis, Daniel S Pine and Monique Ernst Neuropsychopharmacology 2015 40: 1064-1071; advance online publication, November 28, 2014; 10.1038/npp.2014.316 Abstract | Full Text Effects of Oral and Intravenous Administration of Buspirone on Food–Cocaine Choice in Socially Housed Male Cynomolgus Monkeys Paul W Czoty and Michael A Nader Neuropsychopharmacology 2015 40: 1072-1083; advance online publication, November 13, 2014; 10.1038/npp.2014.300 Abstract | Full Text Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial James W Murrough, Katherine E Burdick, Cara F Levitch, Andrew M Perez, Jess W Brallier, Lee C Chang, Alexandra Foulkes, Dennis S Charney, Sanjay J Mathew and Dan V Iosifescu Neuropsychopharmacology 2015 40: 1084-1090; advance online publication, November 6, 2014; 10.1038/npp.2014.298 Abstract | Full Text Mouse Model of the OPRM1 (A118G) Polymorphism: Differential Heroin Self-Administration Behavior Compared with Wild-Type Mice Yong Zhang, Roberto Picetti, Eduardo R Butelman, Ann Ho, Julie A Blendy and Mary Jeanne Kreek Neuropsychopharmacology 2015 40: 1091-1100; advance online publication, October 22, 2014; 10.1038/npp.2014.286 Abstract | Full Text Amphetamine in Adolescence Disrupts the Development of Medial Prefrontal Cortex Dopamine Connectivity in a dcc-Dependent Manner Lauren M Reynolds, Carolina S Makowski, Sandra V Yogendran, Silke Kiessling, Nicolas Cermakian and Cecilia Flores Neuropsychopharmacology 2015 40: 1101-1112; advance online publication, September 22, 2014; 10.1038/npp.2014.287 Abstract | Full Text Early Social Enrichment Rescues Adult Behavioral and Brain Abnormalities in a Mouse Model of Fragile X Syndrome Diego Oddi, Enejda Subashi, Silvia Middei, Luigi Bellocchio, Valerie Lemaire-Mayo, Manuel Guzmán, Wim E Crusio, Francesca R D'Amato and Susanna Pietropaolo Neuropsychopharmacology 2015 40: 1113-1122; advance online publication, October 28, 2014; 10.1038/npp.2014.291 Abstract | Full Text Hypocretin Receptor 2 Antagonism Dose-Dependently Reduces Escalated Heroin Self-Administration in Rats Brooke E Schmeichel, Estelle Barbier, Kaushik K Misra, Candice Contet, Joel E Schlosburg, Dimitri Grigoriadis, John P Williams, Camilla Karlsson, Caleb Pitcairn, Markus Heilig, George F Koob and Leandro F Vendruscolo Neuropsychopharmacology 2015 40: 1123-1129; advance online publication, November 4, 2014; 10.1038/npp.2014.293 Abstract | Full Text Evaluation of Guanfacine as a Potential Medication for Alcohol Use Disorder in Long-Term Drinking Rats: Behavioral and Electrophysiological Findings OPEN Ida Fredriksson, Nitya Jayaram-Lindström, Malin Wirf, Erik Nylander, Erica Nyström, Kent Jardemark and Pia Steensland Neuropsychopharmacology 2015 40: 1130-1140; advance online publication, October 31, 2014; 10.1038/npp.2014.294 Abstract | Full Text Involvement of Cholinergic System in Hyperactivity in Dopamine-Deficient Mice OPEN Yoko Hagino, Shinya Kasai, Masayo Fujita, Susumu Setogawa, Hiroshi Yamaura, Dai Yanagihara, Makoto Hashimoto, Kazuto Kobayashi, Herbert Y Meltzer and Kazutaka Ikeda Neuropsychopharmacology 2015 40: 1141-1150; advance online publication, November 4, 2014; 10.1038/npp.2014.295 Abstract | Full Text Cocaine Increases Dopaminergic Neuron and Motor Activity via Midbrain α1 Adrenergic Signaling Richard Brandon Goertz, Matthew J Wanat, Jorge A Gomez, Zeliene J Brown, Paul EM Phillips and Carlos A Paladini Neuropsychopharmacology 2015 40: 1151-1162; advance online publication, November 6, 2014; 10.1038/npp.2014.296 Abstract | Full Text The Uncompetitive N-methyl-D-Aspartate Antagonist Memantine Reduces Binge-Like Eating, Food-Seeking Behavior, and Compulsive Eating: Role of the Nucleus Accumbens Shell Karen L Smith, Rahul R Rao, Clara Velázquez-Sánchez, Marta Valenza, Chiara Giuliano, Barry J Everitt, Valentina Sabino and Pietro Cottone Neuropsychopharmacology 2015 40: 1163-1171; advance online publication, November 10, 2014; 10.1038/npp.2014.299 Abstract | Full Text Dopaminergic System Dysfunction in Recreational Dexamphetamine Users Anouk Schrantee, Lena Václavů, Dennis F R Heijtel, Matthan W A Caan, Willy Gsell, Paul J Lucassen, Aart J Nederveen, Jan Booij and Liesbeth Reneman Neuropsychopharmacology 2015 40: 1172-1180; advance online publication, November 14, 2014; 10.1038/npp.2014.301 Abstract | Full Text Disrupted Functional and Structural Networks in Cognitively Normal Elderly Subjects with the APOE ε4 Allele Yaojing Chen, Kewei Chen, Junying Zhang, Xin Li, Ni Shu, Jun Wang, Zhanjun Zhang and Eric M Reiman Neuropsychopharmacology 2015 40: 1181-1191; advance online publication, November 18, 2014; 10.1038/npp.2014.302 Abstract | Full Text Evidence Accumulation in Obsessive-Compulsive Disorder: the Role of Uncertainty and Monetary Reward on Perceptual Decision-Making Thresholds Paula Banca, Martin D Vestergaard, Vladan Rankov, Kwangyeol Baek, Simon Mitchell, Tatyana Lapa, Miguel Castelo-Branco and Valerie Voon Neuropsychopharmacology 2015 40: 1192-1202; advance online publication, November 26, 2014; 10.1038/npp.2014.303 Abstract | Full Text Stress during a Critical Postnatal Period Induces Region-Specific Structural Abnormalities and Dysfunction of the Prefrontal Cortex via CRF1 Xiao-Dun Yang, Xue-Mei Liao, Andrés Uribe-Mariño, Rui Liu, Xiao-Meng Xie, Jiao Jia, Yun-Ai Su, Ji-Tao Li, Mathias V Schmidt, Xiao-Dong Wang and Tian-Mei Si Neuropsychopharmacology 2015 40: 1203-1215; advance online publication, November 18, 2014; 10.1038/npp.2014.304 Abstract | Full Text Hippocampal Volume in Healthy Controls Given 3-Day Stress Doses of Hydrocortisone E Sherwood Brown, Haekyung Jeon-Slaughter, Hanzhang Lu, Rhoda Jamadar, Sruthy Issac, Mujeeb Shad, Daren Denniston, Carol Tamminga, Alyson Nakamura and Binu P Thomas Neuropsychopharmacology 2015 40: 1216-1221; advance online publication, November 20, 2014; 10.1038/npp.2014.307 Abstract | Full Text Homer1/mGluR5 Activity Moderates Vulnerability to Chronic Social Stress Klaus V Wagner, Jakob Hartmann, Christiana Labermaier, Alexander S Häusl, Gengjing Zhao, Daniela Harbich, Bianca Schmid, Xiao-Dong Wang, Sara Santarelli, Christine Kohl, Nils C Gassen, Natalie Matosin, Marcel Schieven, Christian Webhofer, Christoph W Turck, Lothar Lindemann, Georg Jaschke, Joseph G Wettstein, Theo Rein, Marianne B Müller and Mathias V Schmidt Neuropsychopharmacology 2015 40: 1222-1233; advance online publication, November 20, 2014; 10.1038/npp.2014.308 Abstract | Full Text Reductions in Frontocortical Cytokine Levels are Associated with Long-Lasting Alterations in Reward Valuation after Methamphetamine Alexandra Stolyarova, Andrew B Thompson, Ruth M Barrientos and Alicia Izquierdo Neuropsychopharmacology 2015 40: 1234-1242; advance online publication, November 20, 2014; 10.1038/npp.2014.309 Abstract | Full Text Myelin vs Axon Abnormalities in White Matter in Bipolar Disorder Kathryn E Lewandowski, Dost Ongür, Sarah H Sperry, Bruce M Cohen, Selma Sehovic, Jacqueline R Goldbach and Fei Du Neuropsychopharmacology 2015 40: 1243-1249; advance online publication, November 20, 2014; 10.1038/npp.2014.310 Abstract | Full Text Childhood Trauma Exposure Disrupts the Automatic Regulation of Emotional Processing Hilary A Marusak, Kayla R Martin, Amit Etkin and Moriah E Thomason Neuropsychopharmacology 2015 40: 1250-1258; advance online publication, November 21, 2014; 10.1038/npp.2014.311 Abstract | Full Text The Neurometabolic Fingerprint of Excessive Alcohol Drinking Marcus W Meinhardt, Daniel C Sévin, Manuela L Klee, Sandra Dieter, Uwe Sauer and Wolfgang H Sommer Neuropsychopharmacology 2015 40: 1259-1268; advance online publication, November 24, 2014; 10.1038/npp.2014.312 Abstract | Full Text Individual Variation in the Motivational and Neurobiological Effects of an Opioid Cue Lindsay M Yager, Kyle K Pitchers, Shelly B Flagel and Terry E Robinson Neuropsychopharmacology 2015 40: 1269-1277; advance online publication, November 26, 2014; 10.1038/npp.2014.314 Abstract | Full Text A Diet Enriched with Curcumin Impairs Newly Acquired and Reactivated Fear Memories Melissa S Monsey, Danielle M Gerhard, Lara M Boyle, Miguel A Briones, Ma'ayan Seligsohn and Glenn E Schafe Neuropsychopharmacology 2015 40: 1278-1288; advance online publication, November 28, 2014; 10.1038/npp.2014.315 Abstract | Full Text The Role of Brain Interleukin-1 in Stress-Enhanced Fear Learning Meghan E Jones, Christina L Lebonville, Daniel Barrus and Donald T Lysle Neuropsychopharmacology 2015 40: 1289-1296; advance online publication, November 28, 2014; 10.1038/npp.2014.317 Abstract | Full Text The Central Amygdala Nucleus is Critical for Incubation of Methamphetamine Craving Xuan Li, Tamara Zeric, Sarita Kambhampati, Jennifer M Bossert and Yavin Shaham Neuropsychopharmacology 2015 40: 1297-1306; advance online publication, December 5, 2014; 10.1038/npp.2014.320 Abstract | Full Text Corrigenda Top Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness Robert E McCullumsmith, John H Hammond, Dan Shan and James H Meador-Woodruff Neuropsychopharmacology 2015 40: 1307; 10.1038/npp.2014.337 Full Text Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders? Gerard Sanacora and Alan F Schatzberg Neuropsychopharmacology 2015 40: 1307; 10.1038/npp.2014.338 Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.